CAS: 1216744-19-2
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
1,1-Dimethylethyl-N-[(4-chlorophenyl)methyl]-N-[(5-nitro-2-thienyl)methyl])glycinate REF: AN-AG009CI5CAS: 1216744-19-2 | 98+% | A consultar | Lun 10 Jun 24 | |
GSK4112 REF: TM-T5045CAS: 1216744-19-2 | 99.63% | 51,00 €~495,00 € | Lun 17 Jun 24 | |
GSK4112 REF: 3D-RYB74419CAS: 1216744-19-2 | Min. 95% | A consultar | Lun 22 Jul 24 | |
GSK 4112 REF: TR-G797700CAS: 1216744-19-2 | - - - | - - - | Producto descatalogado |
1,1-Dimethylethyl-N-[(4-chlorophenyl)methyl]-N-[(5-nitro-2-thienyl)methyl])glycinate
CAS:1216744-19-2
Fórmula:
C18H21ClN2O4S
Pureza:
98+%
Forma y color:
Solid
Peso molecular:
396.8883
Ref: AN-AG009CI5
1g | A consultar | ||
10mg | 55,00 € | ||
50mg | 142,00 € | ||
100mg | 190,00 € | ||
250mg | 319,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Junio de 2024
GSK4112
CAS:1216744-19-2
GSK4112 (SR6452) is a Rev-erbα agonist with EC50 of 0.4 μM, also is a small …
Fórmula:
C18H21ClN2O4S
Pureza:
99.63%
Forma y color:
Solid
Peso molecular:
396.89
Ref: TM-T5045
5mg | 51,00 € | ||
10mg | 83,00 € | ||
25mg | 157,00 € | ||
50mg | 276,00 € | ||
100mg | 495,00 € | ||
1ml*10 (DMSO) | 52,00 € |
Entrega estimada en Estados Unidos, el Lunes 17 de Junio de 2024
GSK4112
CAS:1216744-19-2
GSK4112 is a novel, orally bioavailable compound that is being developed for the treatment of …
Fórmula:
C18H21ClN2O4S
Pureza:
Min. 95%
Peso molecular:
396.89 g/mol
Ref: 3D-RYB74419
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 22 de Julio de 2024
GSK 4112
CAS:1216744-19-2
Applications GSK 4112 is a synthetic ligand for REV-ERBα, a member of the nuclear receptor …
Fórmula:
C18H21ClN2O4S
Forma y color:
Pale Yellow to Light Yellow Solid
Peso molecular:
396.89
Ref: TR-G797700
5mg | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información |